Abstract. 25 Candida auris has become a global public health threat due to its multidrug resistance 26 and persistence in hospital and nursing home settings. Although a skin colonizer, C. auris can 27 cause fatal bloodstream infections and most patients succumb to multi-organ failure. Currently, 28 there are limited animal models to study the progression of C. auris infection. Here we compare 29 two murine models of neutrophil depletion using monoclonal antibodies 1A8, anti-Ly6G + and 30 RB6-8C5 anti-Ly6G + -Ly6C + . We also compare inoculums of 10 7 and 10 8 as well as the 31 intravenous and gavage routes of infection. The results reveal that neutrophil depletion in 32 BALB/c mice is sustained long-term with the 1A8 antibody and short-term with RB6-8C5. 33 Target organs were kidney, heart and brain as these had the highest organ fungal burden in 34 neutrophil depleted and to some extent in infected control mice. We found that C. auris is shed 35 in urine and feces for neutrophil depleted mice. The gavage model is not an ideal route as 36 dissemination was not detected. Eight days post C. auris infection all surviving mice display a 37 unique behavioral phenotype characterized by torticollis and tail spin that progresses to head 38 bobbing and body curling like phenotype by day 22, that continues to persist even 104 days post 39 infection. Lastly, we found C. auris remains in tissues of infected control mice, 34 plus days post 40 infection suggesting that C. auris stays present in the host without causing disease but becomes 41 opportunistic upon a change in the hosts immune status such as neutrophil depletion. alteration of mental status and unsteady gait. However, there was no clear indication whether this 81 was due to C. auris infection (14, 18) . Currently, there are Drosophila melanogaster and 82 Galleria mellonella models for C. auris infection. There are also a limited number of murine 83 models (19, 20) . The current murine models for C. auris infection have used immunocompetent 84 and immunosuppressed models. In the immunocompetent models, mice are infected with 85 inoculums that range from 10 5 to 10 7 cells per animal (21, 22) . However, there appears to be a 86 difference in survival between the studies by Fahkim et al. and Wang et al. (21, 22) . Fakhim et 87 al. used ICR an outbred murine strain and infected them using two clinical isolates from the 88 South Asian clade, that were characterized as non-aggregative and virulent (21) . Fakhim et al. 89 reported a 60%-70% mortality rate by day 17 post-infection (21) . Wang et al. used BALB/c an 90 inbred strain and infected with isolates also from the South Asian clade (22) . These mice did not 91 succumb to infection after 14 days post-infection. Wang et al. attributes this discrepancy to the 92 difference in mouse strains and differences in C. auris isolates (22) . The murine models of 93 immunosuppression use the chemotherapeutic agent cyclophosphamide, or a combination of 94 cyclophosphamide and cortisone acetate (23, 24) . These models work well in achieving infection 95 and for evaluating the efficacy of a particular treatment such as antifungal and vaccine 96 candidates against C. auris (23, 24). However, a limitation of using cyclophosphamide is that it 97 depletes cells of both the innate and the adaptive immune system (25) . At high doses of 98 cyclophosphamide ≥200mg/kg, these deplete Tregs, CD8 + DCs, B-cells and CD4 + and CD8 + T-99 cells that may be important in immunological studies in response to C. auris (23, 24, (26) (27) (28) (29) . To develop a model of C. auris infection as a tool to understand pathogenesis, we tested 102 several variables in BALB/c mice such as whether we could obtain infection by a sustained neutrophil depletion with anti-neutrophil antibodies 1A8 and RB6-8C5. We also tested different 104 inoculums of 10 7 and 10 8 C. auris cells and different routes of infection such as intravenous and 105 gavage. Here we report that in addition to finding differences in the tested variables we also noted that RB6-8C5 treated mice infected with an inoculum of 10 8 by day 1 displayed a hunched 140 posture, swollen shut eyes and rough coat as previously described (21), (Fig. 2B ). By day 1 post 141 infection the 1A8 treated mice, with a 10 8 inoculum, showed a normal posture and slightly rough 142 coat. However, both neutrophil depleted groups eventually died by days 3 and 4 and therefore 143 did not represent an ideal model to study the course of infection ( Fig. 2A ). Mice infected via 144 gavage did not show signs of illness and there was 100% survival regardless of which neutrophil 145 depletion antibody or inoculums that were used ( Fig. 2A) . At a dose of 10 7 , we noted differences 146 in the appearance of mice, depending on the neutrophil depletion antibody that was used. The 147 RB6-8C5 treated mice showed signs of illness as early as day 1 as determined by a rough erect 148 coat, hunched-back and had lost 20% loss of their weight by day 7 (Fig. 2F ). At this inoculum, 149 using RB6-8C5, there was a 60% survival rate and the surviving mice recovered 15% of their 150 starting weight by day 16 which may be due to the immune system overcompensating for the 151 neutrophil depletion. The mice treated with 1A8 showed signs of illness by days 5 and 6 152 determined by a rough erect coat, hunched-back and 15% loss of their weight by day 7. For 1A8, 153 40% of the mice survived, and those recovered 5% of their weight by day 16 (Fig. 2C and 2E ). 154 Infected control mice at inoculums of 10 8 and 10 7 showed slightly rough coats by days 1 and 2 155 but there was 100% survival in both groups. At the 10 8 inoculum mice lost 3% body weight by 156 day 10 and the mice inoculated 10 7 lost 5% weight by day 17 ( Fig. 2A and 2E ). We measured fungal organ burdens 7 days post infection in mice that were infected with 159 an inoculum of 10 7 C. auris cells to determine which organs were affected by C. auris. We also 160 compared differences based on the neutrophil depletion antibody that was used and the route of 161 infection. For i.v. infected mice, we found that the kidney, heart, and brain were the organs with 162 the highest fungal burden regardless of which neutrophil depleting antibody was used. For 163 kidney and heart in i.v. infected mice, we found a fungal organ burden of 10 5 CFU/g and 10 4 164 CFU/g in the brain (Fig. 3) . In other organs such as the bladder, uterus, spleen, cecum, small 165 intestine, stomach and lungs from i.v. infected mice, we found modest levels of fungal burden 166 that ranged from 10 1 -10 3 CFU/g. We found enhanced organ fungal burden in neutrophil depleted 167 mice with RB6-8C5 ( Fig. S1 ). We did not find organ fungal burden in either kidney or brain in 168 the gavage model but we found modest fungal burdens in the cecum, small intestine and stomach 169 ( Fig. S1 ). To confirm that the colonies that were detected on our plates were C. auris, we 170 performed MALDI-TOF on samples from harvested organs. The results reveal that all tissues 171 were infected with C. auris (Table S1 ).
In order to evaluate and score C. auris infected tissues, we determined that the fixation 174 time frame in 10% formalin was 24 hours to fully inactivate C. auris. We determined this by 175 culture and by counting CFU in infected formalin fixed tissues ( Fig. S2 ). Histology was done 176 using the standard hematoxylin-eosin (H&E) staining as well as by immunohistochemistry (IHC) 177 staining for C. auris with an anti-Candida albicans polyclonal antibody that we found to cross 178 react (Thermofisher, Waltham MA). Significant histopathological changes were observed in 1A8 179 and RB6-8C5 treated neutrophil depleted mice that were challenged with C. auris intravenously. 180 We also found moderate changes in i.v. infected control mice. For all three groups, the kidney, 181 heart, and brain were most affected, followed by the liver, gastrointestinal tract, and spleen ( Fig   182   4 and Table 1 ). In the kidneys, there was a multi-focal-to-coalescing necrotizing tubulointerstitial neutrophils. This infiltrate was often expanding between myofibers in areas where the organ 192 architecture was still intact. In the infected control mice, the severity of inflammation was 193 minimal and necrosis was absent. Brain damage was more prominent in infected animals treated 194 with the 1A8 antibody. In these animals, there were multiple microabscesses and large foci of necrosis and edema throughout the brain. These areas of inflammation were infiltrated by 196 macrophages, glial cells, and a few neutrophils ( Fig 4 and Table 1 ). 197 198 Damage in the liver ranged from mild in infected control mice to moderate in infected 199 1A8 and RB6-8C5 treated mice. We observed a diffuse suppurative hepatitis, characterized by We also found various degrees of extramedullary hematopoiesis (EMH) in the liver, 210 spleen, and lungs, which was more prominent in infected 1A8 and RB6-8C5 treated mice. 211 Animals treated with RB6-8C5 and challenged i.v. with PBS or by gavage with C. auris, also 212 exhibited various degrees of EMH in the liver and lungs (data not shown). Overall, tissues from 213 control animals challenged i.v. with PBS or with C. auris by gavage, regardless of the treatment 214 group, were within normal limits (data not shown). Table 1 ).
232
Immunostaining was not prominent in liver tissues. We found few scattered neutrophils, 233 macrophages, and microabscesses were positive, and rarely intact yeast in sinusoids. In the 234 gastrointestinal tract, antigen was also highlighted in the Peyer's patches and lymphoid follicles 235 of the small intestine in all groups (Fig. S3 ). C. auris antigen was also detected in the spleen of 236 all neutrophil depleted and infected control mice but notably more prominent in those treated 237 with RB6-8C5, followed by 1A8 and non-treated consecutively. In the lungs, antigen was only 238 detected in the treated groups (Table 1) . Lastly, antigen was detected in the endometrium of 1A8 239 and RB6-8C5 treated animals as well as in peritoneal fat microabscesses (Table 1 and Fig S3) . 240 Additionally, 34 days post infection, in infected control mice, we found the presence of C. auris yeast and antigen in kidney, heart, brain, lung, spleen, meninges, stomach, PPs and uterus (Fig. 242 5). 243 In humans C. auris has been identified to be excreted in urine. Histopathology indicated 244 that the organism was present in the renal tubes and pelvis in our model (1). We tested urine and 245 feces either by qPCR or culture to determine whether mice were shedding C. auris. The results 246 reveal that viable C. auris is shed in urine and we were able to detect an output of 10 2 CFU/µl 247 from mice that had initially been infected i.v. with 10 7 C. auris cells ( Fig. 6A ). We also found C. 248 auris in the feces ranging from 10 4 -10 5 CFU/ µl in both the i.v. and gavage models. We noted 249 that neutrophil depleted mice with RB6-8C5 had a one log difference in CFUs ( Fig. 6A ). qPCR 250 performed in feces revealed that C. auris i.v. infected mice had a cycle threshold value (Ct) of 251 33.18±1.65 for RB6-8C5. Infection by gavage showed a Ct value 31.7±1.81 for RB6 ( Fig. 6 ). (21). We observed that between days 8-13, 50% of the 261 mice exhibiting torticollis oriented to the right and 50% oriented to the left ( Fig. 8 and Movie 1). 262 When these mice were elevated by the tail they exhibited a forceful spin on their tails until they 263 were set back down ( Fig. 8 and Movie 2). Twenty-two days after the torticollis appears, 50% of 264 the mice exhibited a rapid head bobbing along with fast and erratic movement in the cage ( Fig. 8   265 and Movie 3). We found that a head bobbing does not revert back to torticollis. When these mice 266 are then elevated by their tails the head bobbing mice exhibit a curling like behavior ( Fig.8 and   267 Movie 4). Interestingly, the head bobbing behavior does not revert to torticollis. Histology of the 268 cerebellum an area important in balance, coordination and muscular activity did not show the 269 presence of C. auris therefore further analysis of the inner ear is required to understand this 270 phenotype. Surviving control mice that were infected with 10 7 and 10 8 C. auris cells were 271 followed for 104 days post infection. These mice continued to exhibit the head bobbing along 272 with fast and erratic movement in the cage (Movie 5).
274
Discussion. 275 Since its identification in 2009, Candida auris has become a major public health threat 276 due to its unpredictable multidrug resistance profile, high transmissibility, particularly in nursing 277 home and healthcare settings and high mortality rates of 30%-60%. Currently, there are a limited 278 number of murine models of C. auris infection that can be used to study disease progression. 279 Although there are immunocompetent models of infection there are discrepancies in survival 280 based on the murine strains and isolates used (21, 22) . The immunosuppressed models use 281 cyclophosphamide, which depletes the entire immune system to allow for C. auris dissemination 282 but limits studies that test host immunity against this pathogen(24). Here we compare two mouse 283 models that achieve immunosuppression by depleting neutrophils using 1A8, anti-Ly6G + which 284 depletes neutrophils only and RB6-8C5, anti-Ly6G + -Ly6C + which depletes neutrophils and 285 Ly6G monocytes(30). We chose to deplete neutrophils as it was recently documented that 286 neutrophils poorly recruit C. auris and failed to form neutrophil extracellular traps (NETs), 287 structures of DNA, histones, and proteins with antimicrobial activity (32). Since C. auris evades neutrophil attack, the 1A8 and RB6-8C5 models can be used to further elucidate how C. 289 auris takes advantage of the host in the absence of neutrophils (32). Both models were useful as 290 these as 1A8 represents long term depletion while RB6-8C5 represents short term depletion.
292
Our models also confirm that an inoculum of 10 7 C. auris cells is optimal to study C. 293 auris progression as previously documented (21, 22) . We found that the major target organs were 294 kidney, heart and brain which recapitulates human infection where patients have been found to 295 have kidney failure and endocarditis (14-17). The presence of C. auris in kidney tubules detected 296 by histology as well as the presence in urine and feces shows that the neutrophil depletion 297 models recapitulate shedding in humans (33). By histology we found that in addition to yeast 298 cells in tissues, there was the presence of granular-to-homogenous intracytoplasmic stain which 299 may be secreted by C. auris or processed antigen; an area to be further investigated. 300 Interestingly, we noted that between 8-13 days post C. auris infection, mice displayed a unique infected by the i.v. route were with CFU/g ranging from 10 4 -10 6 . The oral gavage route is not optimal to establish a C. or neutropenic, displayed a behavioral phenotype. 8-13 days post infection mice displayed torticollis (characterized by a lean) when 738 these mice were elevated by the tail they began to spin. By day 22 post infection, mice displayed head bobbing movement, these mice 739 when elevated by the tail showed curling. Mice exhibiting f head bobbing did not appear to revert by to torticollis. Fig 2: 10% Formalin is effective at inactivating C. auris in mouse tissues after 24 hours. C. auris was incubated 757 in either Sabouraud broth or 10% Formalin at 2, 4, 6, 24, or 48 hours. Within 2 hours, C. auris is no longer growing when plated. The 758 table shows tissues collected from mice exposed to different inoculums of C. auris. These were incubated in either HBSS or 10% 759 formalin. After either 24 and 72 hours, tissues were washed and plated for growth. There was no growth in tissues incubated for 24 760 hours in 10% formalin. TN= Too numerous to count. 
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